Stay updated on ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Sign up to get notified when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.

Latest updates to the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a consolidated Locations section with state entries (Arizona, California, Maryland, Massachusetts), replacing the previous location blocks. Included revision note v3.3.3 and removed the HHS Vulnerability Disclosure link.SummaryDifference0.5%

- Check61 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.2. Removed the older PubMed sourcing note and revision v3.2.0.SummaryDifference0.1%

- Check68 days agoChange DetectedRemoved the generic government funding/operating status notice from the page; the study details and other content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedNo significant changes detected in core study details or design. The page information remains consistent with the prior version.SummaryDifference0.4%

- Check111 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.